Michael Groeneweg

BACKGROUND: Effective and safe pharmacologic treatments are lacking for children with Irritable Bowel Syndrome (IBS) and Functional Abdominal Pain – Not otherwise specified (FAP-NOS). We evaluated the efficacy and safety of mebeverine, an antispasmodic agent…